ProShares UltraShort Nasdaq Biotechnology (BIS) Holdings $17.84 -0.47 (-2.54%) As of 05/2/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock Top 7 BIS HoldingsRankCompanyCurrent PriceWeightShares Held1NET OTHER ASSETS (LIABILITIES)N/A0.00%3,064,4642TREASURY BILLN/A0.00%100,0003NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A-13.25%-1004NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A-27.95%-2115NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A-30.99%-2346NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A-63.71%-4817NASDAQ BIO INDEX SWAP BNP PARIBASN/A-63.84%-482 Geographic ExposureUnited States3.2%Currency ExposureUSD84.6% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Holdings First Trust Nasdaq Pharmaceuticals ETF Holdings Horizon Kinetics Medical ETF Holdings Global X HealthTech ETF Holdings Invesco Nasdaq Biotechnology ETF Holdings ProShares Ultra Nasdaq Biotechnology Holdings F/m Emerald Life Sciences Innovation ETF Holdings Invesco Dorsey Wright Healthcare Momentum ETF Holdings Invesco S&P SmallCap Health Care ETF Holdings VanEck Biotech ETF Holdings This page (NASDAQ:BIS) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhile fear dominates the headlines, a silent breakthrough could turn panic into profit. The future of AI fa...True Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIS Stock Free BIS Stock Alerts